Grufity logo
Grufity logo

Latest Logos Global Management LP Stock Portfolio

$2.32Billion | No. of Holdings #68

Logos Global Management LP Performance

2026 Q2+14.53%
YTD+29.44%
2025+32.36%

About Logos Global Management LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Logos Global Management LP reported an equity portfolio of $2.3 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Logos Global Management LP are ERAS, , RVMD. The fund has invested 9.6% of it's portfolio in ERASCA INC and 5.9% of portfolio in ABIVAX SA. <br><br> The fund managers got completely rid off CENTESSA PHARMACEUTICALS PLC (CNTA), CYTOKINETICS INC (CYTK) and UNITED THERAPEUTICS CORP DEL (UTHR) stocks. They significantly reduced their stock positions in RHYTHM PHARMACEUTICALS INC (RYTM), ACADIA PHARMACEUTICALS INC (ACAD) and REVOLUTION MEDICINES INC (RVMD). Logos Global Management LP opened new stock positions in BIONTECH SE (BNTX), VERA THERAPEUTICS INC (VERA) and BELITE BIO INC (BLTE). The fund showed a lot of confidence in some stocks as they added substantially to FAETH THERAPEUTICS INC (SNSE), VERADERMICS INC and CELLDEX THERAPEUTICS INC NEW (CLDX).
Logos Global Management LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$2.32Billion
  as of Aug 14, 2026

Logos Global Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Logos Global Management LP made a return of 14.53% in the last quarter. In trailing 12 months, it's portfolio return was 102.47%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
biontech se94,445,800
vera therapeutics inc94,402,000
belite bio inc38,496,200
achieve life science inc35,425,200
cogent biosciences inc34,830,000
compass pathways plc31,837,500
mineralys therapeutics inc28,329,000
replimune group inc27,675,000
New stocks bought by Logos Global Management LP

Additions

Ticker% Inc.
faeth therapeutics inc2,306
veradermics inc620
celldex therapeutics inc new366
crescent biopharma inc.293
avalo therapeutics inc283
arrivent biopharma inc185
jade biosciences inc181
dianthus therapeutics inc100
Additions to existing portfolio by Logos Global Management LP

Reductions

Ticker% Reduced
rhythm pharmaceuticals inc-72.22
acadia pharmaceuticals inc-66.67
revolution medicines inc-65.00
aclaris therapeutics inc-60.00
immunocore hldgs plc-60.00
relay therapeutics inc-53.33
tenax therapeutics inc-52.00
amylyx pharmaceuticals inc-50.00
Logos Global Management LP reduced stake in above stock

Sold off

Ticker$ Sold
compass therapeutics inc-16,663,500
centessa pharmaceuticals plc-84,405,000
ibio inc-2,470,000
janux therapeutics inc-13,900,000
verastem inc-5,300,000
oric pharmaceuticals inc-12,036,500
cytokinetics inc-57,671,200
tyra biosciences inc-32,555,000
Logos Global Management LP got rid off the above stocks

Sector Distribution

Logos Global Management LP has about 65.6% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare65.6
Others34.4

Market Cap. Distribution

Logos Global Management LP has about 6.5% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
Category%
MID-CAP41.3
UNALLOCATED34.4
SMALL-CAP15.7
LARGE-CAP6.5
MICRO-CAP1.2

Stocks belong to which Index?

About 50.8% of the stocks held by Logos Global Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200050.8
Others49.2
Top 5 Winners (%)%
fractyl health inc
73.5 %
RLAY
relay therapeutics inc
64.6 %
RVMD
revolution medicines inc
62.5 %
TRVI
trevi therapeutics inc
50.2 %
TNGX
tango therapeutics inc
48.2 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
121.5 M
TNGX
tango therapeutics inc
30.2 M
ERAS
erasca inc
24.9 M
abivax sa
18.6 M
TRVI
trevi therapeutics inc
14.4 M
Top 5 Losers (%)%
PTN
palatin technologies inc
-36.7 %
UNCY
unicycive therapeutics inc
-28.7 %
OLMA
olema pharmaceuticals inc
-16.1 %
SNSE
faeth therapeutics inc
-12.0 %
NERV
minerva neurosciences inc
-7.8 %
Top 5 Losers ($)$
OLMA
olema pharmaceuticals inc
-7.7 M
SNSE
faeth therapeutics inc
-2.5 M
NERV
minerva neurosciences inc
-1.5 M
PTN
palatin technologies inc
-0.9 M
UNCY
unicycive therapeutics inc
-0.9 M

Logos Global Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Logos Global Management LP

Logos Global Management LP has 68 stocks in it's portfolio. About 48.3% of the portfolio is in top 10 stocks. OLMA proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Logos Global Management LP last quarter.

$2.32BTotal Value
87.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Logos Global Management LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
BLTE
Belite Bio Inc

Belite Bio Inc

BLTE
Logos Global Management LP's holding in Belite Bio Inc over time
1.66%250,000
$38.50M
1.66%
new position
BNTX
Biontech Se

Biontech Se

BNTX
Logos Global Management LP's holding in Biontech Se over time
4.07%1,015,000
$94.45M
4.07%
new position
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
Logos Global Management LP's holding in Compass Pathways Plc over time
1.37%2,250,000
$31.84M
1.37%
new position
CYBN
Cybin Inc

Cybin Inc

CYBN
Logos Global Management LP's holding in Cybin Inc over time
0.21%750,000
$4.96M
0.21%
new position